Your browser doesn't support javascript.
loading
Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational study.
Nakamoto, Shogo; Shien, Tadahiko; Itoh, Mitsuya; Yamamoto, Yutaka; Ohsumi, Shozo; Yoshitomi, Seiji; Hikino, Hajime; Miyoshi, Kazuya; Notsu, Akifumi; Taira, Naruto; Doihara, Hiroyoshi; Ikeda, Masahiko.
Afiliación
  • Nakamoto S; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. p92c9f20@s.okayama-u.ac.jp.
  • Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Itoh M; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Yamamoto Y; Department of Breast and Thyroid Surgery, Kawasaki Medical School Hospital, Kurashiki, Japan.
  • Ohsumi S; Department of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan.
  • Yoshitomi S; Department of Breast and Endocrine Surgery, Red Cross Okayama Hospital, Okayama, Japan.
  • Hikino H; Department of Breast Surgery, Matsue Red Cross Hospital, Matsue, Japan.
  • Miyoshi K; Department of Breast and Endocrine Surgery, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan.
  • Notsu A; Clinical Research Center, Shizuoka Cancer Center, Nagaizumi-cho, Japan.
  • Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
  • Doihara H; Department of Breast and Thyroid Surgery, Kawasaki Medical School Hospital, Kurashiki, Japan.
  • Ikeda M; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Clin Exp Med ; 23(8): 5129-5138, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37904008

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Humans Idioma: En Revista: Clin Exp Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Humans Idioma: En Revista: Clin Exp Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Italia